Cardiac Sarcoidosis: Detected by Delayed-Hyperenhancement Magnetic Resonance Imaging

Texas Heart Institute Journal

Volumn 31, Issue 1, 2004, Pages 99-102

  Nemeth, Margit A ^a   Muthupillai, Raja ^b   Wilson, James M ^a   Awasthi, Mukta ^a   Flamm, Scott D ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

Arrhythmia etiology; Contrast media; Gadolinium DTPA diagnostic use; Magnetic resonance imaging methods; Myocardial diseases diagnosis radionuclide imaging; Sarcoidosis diagnosis complications radionuclide imaging

Indexed keywords

FLUTICASONE; GADOLINIUM PENTETATE; IPRATROPIUM BROMIDE; LIDOCAINE; SALBUTAMOL; SALMETEROL; STEROID; THEOPHYLLINE; VERAPAMIL;

ADULT; APPARATUS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; COUGHING; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART DISEASE; HEART PALPITATION; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; SARCOIDOSIS; SYMPTOM; TACHYCARDIA; THORAX PAIN; TREATMENT FAILURE;

CARDIOMYOPATHIES; FEMALE; FIBROSIS; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING, CINE; MIDDLE AGED; SARCOIDOSIS; TACHYCARDIA, VENTRICULAR;

EID: 1642327584     PISSN: 07302347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Fleming HA. Cardiac sarcoidosis. Seminars in Respiratory Medicine 1986;8:65-71.
2. Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest 1993;103(1):253-8.
3. Bernstein M, Konzlemann FW, Sidlick DM. Boeck's sarcoid: report of a case with visceral involvement. Arch Intern Med 1929;44:721-34.
4. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977;63(1):86-108.
5. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978;58(6):1204-11.
6. Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 1995;119(2): 167-72.
7. Longcope WT, Friedman DG. A study of sarcoidosis. Based on a combined investigation of 160 cases including 30 autopsies from the Johns Hopkins Hospital and Massachusetts General Hospital. Medicine 1952;31:1-132.
8. Haywood LJ, Sharma OP, Siegel ME, Siegel RJ, Gottlieb SL, Caldwell J, Siemsen JK. Detection of myocardial sarcoidosis by thallium 201 imaging. J Natl Med Assoc 1982; 74(10):959-64.
9. Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002;105(2):224-9.
10. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343(20):1445-53.
11. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100(19):1992-2002.
12. Klein C, Nekolla SG, Bengel FM, Momose M, Sammer A, Haas F, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105 (2):162-7.
13. Chandra M, Silverman ME, Oshinski J, Pettigrew R. Diagnosis of cardiac sarcoidosis aided by MRI. Chest 1996; 110(2):562-5.
14. Doherty MJ, Kumar SK, Nicholson AA, McGivern DV. Cardiac sarcoidosis: the value of magnetic resonance imaging in diagnosis and assessment of response to treatment. Respir Med 1998;92(4):697-9.
15. Vignaux O, Dhote R, Duboc D, Blanche P, Dusser D, Weber S, Legmann P. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 2002;122(6):1895-901.